Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis.

Francess Victoria Nelson Danquah, Lani Zimmerman, Pamela M. Diamond, Janet Meininger, Nancy Bergstrom

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The purpose of this study was to determine which symptoms are the most reported occur most frequently, have the greatest severity, and cause the most bother for patients on hemodialysis (HD), and to determine if the symptoms experienced differ between the first (HD1) and second (HD2) treatments of the week. An observational, comparative design was used to determine participants' HD symptoms experienced on HD1 and HD2, and the effect of the symptom experience on quality of life (QOL). One hundred subjects were recruited from five dialysis centers. The adapted Dialysis Frequency, Severity, and Symptom Burden Index (DFSSBI) and the Medical Outcomes Study Short Form 36 (MOS SF 36) were administered (N = 99) on HD1 and the DFSSBI again on HD2. Data were analyzed for significance among symptom experience test scores in relation to HD1 and HD2, QOL, and gender and age. Of 31 symptoms assessed respondents reported an average of 9.77 symptoms on HD1 and 7.51 symptoms on HD2. Overall, more symptoms were reported and were more frequent, severe, and bothersome on HD1 when the level of metabolic waste is highest. The most reported symptoms included tiredness, dry skin, difficulty falling asleep, itching, numbness/tingling, difficulty staying asleep, decreased interest in sex, and bone/joint pain. Females scored consistently higher than males in the four symptom dimensions. Respondents reported about the same as the population norm (50) on the physical component summary score of the MOS SF 36 and higher than the norm (65.23) on the mental component summary score. The study found patients on HD experience multiple symptoms that can be frequent, severe, and bothersome. Interventions should be developed and tested to reduce symptom bother and improve QOL.

Original languageEnglish (US)
Pages (from-to)627-638; quiz 639
JournalNephrology nursing journal : journal of the American Nephrology Nurses' Association
Volume37
Issue number6
StatePublished - Nov 1 2010

Fingerprint

Renal Dialysis
Dialysis
Quality of Life
Outcome Assessment (Health Care)
Hypesthesia
Arthralgia
Pruritus
Bone and Bones
Skin
Population
Surveys and Questionnaires
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis. / Danquah, Francess Victoria Nelson; Zimmerman, Lani; Diamond, Pamela M.; Meininger, Janet; Bergstrom, Nancy.

In: Nephrology nursing journal : journal of the American Nephrology Nurses' Association, Vol. 37, No. 6, 01.11.2010, p. 627-638; quiz 639.

Research output: Contribution to journalArticle

Danquah, Francess Victoria Nelson ; Zimmerman, Lani ; Diamond, Pamela M. ; Meininger, Janet ; Bergstrom, Nancy. / Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis. In: Nephrology nursing journal : journal of the American Nephrology Nurses' Association. 2010 ; Vol. 37, No. 6. pp. 627-638; quiz 639.
@article{ee695677379b44efb808c20abe950153,
title = "Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis.",
abstract = "The purpose of this study was to determine which symptoms are the most reported occur most frequently, have the greatest severity, and cause the most bother for patients on hemodialysis (HD), and to determine if the symptoms experienced differ between the first (HD1) and second (HD2) treatments of the week. An observational, comparative design was used to determine participants' HD symptoms experienced on HD1 and HD2, and the effect of the symptom experience on quality of life (QOL). One hundred subjects were recruited from five dialysis centers. The adapted Dialysis Frequency, Severity, and Symptom Burden Index (DFSSBI) and the Medical Outcomes Study Short Form 36 (MOS SF 36) were administered (N = 99) on HD1 and the DFSSBI again on HD2. Data were analyzed for significance among symptom experience test scores in relation to HD1 and HD2, QOL, and gender and age. Of 31 symptoms assessed respondents reported an average of 9.77 symptoms on HD1 and 7.51 symptoms on HD2. Overall, more symptoms were reported and were more frequent, severe, and bothersome on HD1 when the level of metabolic waste is highest. The most reported symptoms included tiredness, dry skin, difficulty falling asleep, itching, numbness/tingling, difficulty staying asleep, decreased interest in sex, and bone/joint pain. Females scored consistently higher than males in the four symptom dimensions. Respondents reported about the same as the population norm (50) on the physical component summary score of the MOS SF 36 and higher than the norm (65.23) on the mental component summary score. The study found patients on HD experience multiple symptoms that can be frequent, severe, and bothersome. Interventions should be developed and tested to reduce symptom bother and improve QOL.",
author = "Danquah, {Francess Victoria Nelson} and Lani Zimmerman and Diamond, {Pamela M.} and Janet Meininger and Nancy Bergstrom",
year = "2010",
month = "11",
day = "1",
language = "English (US)",
volume = "37",
pages = "627--638; quiz 639",
journal = "Nephrology Nursing Journal",
issn = "1526-744X",
publisher = "Jannetti Publications, Inc.",
number = "6",

}

TY - JOUR

T1 - Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis.

AU - Danquah, Francess Victoria Nelson

AU - Zimmerman, Lani

AU - Diamond, Pamela M.

AU - Meininger, Janet

AU - Bergstrom, Nancy

PY - 2010/11/1

Y1 - 2010/11/1

N2 - The purpose of this study was to determine which symptoms are the most reported occur most frequently, have the greatest severity, and cause the most bother for patients on hemodialysis (HD), and to determine if the symptoms experienced differ between the first (HD1) and second (HD2) treatments of the week. An observational, comparative design was used to determine participants' HD symptoms experienced on HD1 and HD2, and the effect of the symptom experience on quality of life (QOL). One hundred subjects were recruited from five dialysis centers. The adapted Dialysis Frequency, Severity, and Symptom Burden Index (DFSSBI) and the Medical Outcomes Study Short Form 36 (MOS SF 36) were administered (N = 99) on HD1 and the DFSSBI again on HD2. Data were analyzed for significance among symptom experience test scores in relation to HD1 and HD2, QOL, and gender and age. Of 31 symptoms assessed respondents reported an average of 9.77 symptoms on HD1 and 7.51 symptoms on HD2. Overall, more symptoms were reported and were more frequent, severe, and bothersome on HD1 when the level of metabolic waste is highest. The most reported symptoms included tiredness, dry skin, difficulty falling asleep, itching, numbness/tingling, difficulty staying asleep, decreased interest in sex, and bone/joint pain. Females scored consistently higher than males in the four symptom dimensions. Respondents reported about the same as the population norm (50) on the physical component summary score of the MOS SF 36 and higher than the norm (65.23) on the mental component summary score. The study found patients on HD experience multiple symptoms that can be frequent, severe, and bothersome. Interventions should be developed and tested to reduce symptom bother and improve QOL.

AB - The purpose of this study was to determine which symptoms are the most reported occur most frequently, have the greatest severity, and cause the most bother for patients on hemodialysis (HD), and to determine if the symptoms experienced differ between the first (HD1) and second (HD2) treatments of the week. An observational, comparative design was used to determine participants' HD symptoms experienced on HD1 and HD2, and the effect of the symptom experience on quality of life (QOL). One hundred subjects were recruited from five dialysis centers. The adapted Dialysis Frequency, Severity, and Symptom Burden Index (DFSSBI) and the Medical Outcomes Study Short Form 36 (MOS SF 36) were administered (N = 99) on HD1 and the DFSSBI again on HD2. Data were analyzed for significance among symptom experience test scores in relation to HD1 and HD2, QOL, and gender and age. Of 31 symptoms assessed respondents reported an average of 9.77 symptoms on HD1 and 7.51 symptoms on HD2. Overall, more symptoms were reported and were more frequent, severe, and bothersome on HD1 when the level of metabolic waste is highest. The most reported symptoms included tiredness, dry skin, difficulty falling asleep, itching, numbness/tingling, difficulty staying asleep, decreased interest in sex, and bone/joint pain. Females scored consistently higher than males in the four symptom dimensions. Respondents reported about the same as the population norm (50) on the physical component summary score of the MOS SF 36 and higher than the norm (65.23) on the mental component summary score. The study found patients on HD experience multiple symptoms that can be frequent, severe, and bothersome. Interventions should be developed and tested to reduce symptom bother and improve QOL.

UR - http://www.scopus.com/inward/record.url?scp=79952261064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952261064&partnerID=8YFLogxK

M3 - Article

C2 - 21290917

AN - SCOPUS:79952261064

VL - 37

SP - 627-638; quiz 639

JO - Nephrology Nursing Journal

JF - Nephrology Nursing Journal

SN - 1526-744X

IS - 6

ER -